Lipocine Stock Forecast, Price & News

Lipocine (NASDAQ:LPCN) Frequently Asked Questions

Is Lipocine a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lipocine in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Lipocine stock.
View analyst ratings for Lipocine or view top-rated stocks.

How has Lipocine's stock been impacted by COVID-19?

Lipocine's stock was trading at $0.4511 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LPCN shares have increased by 112.7% and is now trading at $0.9594.
View which stocks have been most impacted by COVID-19.

When is Lipocine's next earnings date?

Lipocine is scheduled to release its next quarterly earnings announcement on Thursday, March 10th 2022.
View our earnings forecast for Lipocine.

How were Lipocine's earnings last quarter?

Lipocine Inc. (NASDAQ:LPCN) issued its quarterly earnings results on Wednesday, November, 10th. The specialty pharmaceutical company reported ($0.03) EPS for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.01. The specialty pharmaceutical company earned $0.06 million during the quarter.
View Lipocine's earnings history.

What price target have analysts set for LPCN?

2 equities research analysts have issued twelve-month target prices for Lipocine's stock. Their forecasts range from $3.00 to $3.50. On average, they anticipate Lipocine's share price to reach $3.25 in the next year. This suggests a possible upside of 238.8% from the stock's current price.
View analysts' price targets for Lipocine or view top-rated stocks among Wall Street analysts.

Who are Lipocine's key executives?

Lipocine's management team includes the following people:

• Mahesh V. Patel, Chairman, President & Chief Executive Officer
• Morgan R. Brown, Chief Financial Officer & Executive Vice President
• Anthony DelConte, Chief Medical Director
• Nachiappan Chidambaram, Vice President-Product Development
• Hans Vitzthum, Head-Investors Relation Contact

Who are some of Lipocine's key competitors?

Some companies that are related to Lipocine include Adagene (ADAG), Zomedica (ZOM), AC Immune (ACIU), XBiotech (XBIT), VistaGen Therapeutics (VTGN), Omeros (OMER), Immuneering (IMRX), Pyxis Oncology (PYXS), Clovis Oncology (CLVS), Viking Therapeutics (VKTX), Sernova (SEOVF), ProQR Therapeutics (PRQR), Nanobiotix (NBTX), Annexon (ANNX) and Radius Health (RDUS).
View all of LPCN's competitors.

What other stocks do shareholders of Lipocine own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lipocine investors own include Synergy Pharmaceuticals (SGYP), Flexion Therapeutics (FLXN), Trevena (TRVN), Heat Biologics (HTBX), Rigel Pharmaceuticals (RIGL), Inovio Pharmaceuticals (INO), SCYNEXIS (SCYX), Dynavax Technologies (DVAX), Biocept (BIOC) and Catalyst Pharmaceuticals (CPRX).

What is Lipocine's stock symbol?

Lipocine trades on the NASDAQ under the ticker symbol "LPCN."

How do I buy shares of Lipocine?

Shares of LPCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lipocine's stock price today?

One share of LPCN stock can currently be purchased for approximately $0.96.

How much money does Lipocine make?

Lipocine has a market capitalization of $84.71 million and generates $170 thousand in revenue each year. The specialty pharmaceutical company earns $-20.96 million in net income (profit) each year or ($0.21) on an earnings per share basis.

How many employees does Lipocine have?

Lipocine employs 11 workers across the globe.

What is Lipocine's official website?

The official website for Lipocine is www.lipocine.com.

Where are Lipocine's headquarters?

Lipocine is headquartered at 675 ARAPEEN DRIVE SUITE 202, SALT LAKE CITY X1, 84108.

How can I contact Lipocine?

Lipocine's mailing address is 675 ARAPEEN DRIVE SUITE 202, SALT LAKE CITY X1, 84108. The specialty pharmaceutical company can be reached via phone at (801) 994-7383, via email at [email protected], or via fax at 801-994-7388.